Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Dose Proportionality of Infacort Versus Hydrocortisone in Healthy Male Volunteers
NCT02777268Phase 1Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Jul 2013
- Primary completion
- Sep 2013
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of hydrocortisone in adrenal insufficiency (AI) (5 arms), sponsored by Neurocrine Biosciences. Primary endpoints: Maximum Plasma Concentration at 12 hours, Time to Reach the Maximum Plasma Concentration at 12 hours and 1 more. Started Jul 2013; status: completed.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT02777268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777268.